Yabao Pharmaceutical Group Co Ltd (600351) — Cash Flow Reinvestment Rate
Yabao Pharmaceutical Group Co Ltd (600351) has a Cash Flow Reinvestment Rate of 0.06x as of September 2025, reinvesting CN¥7.58 Million (capex CN¥7.58 Million ) from operating cash flow of CN¥129.49 Million. Explore Yabao Pharmaceutical Group Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Yabao Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (2001–2024)
Historical reinvestment intensity for Yabao Pharmaceutical Group Co Ltd across 22 annual periods. Also explore balance sheet size of Yabao Pharmaceutical Group Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Yabao Pharmaceutical Group Co Ltd (2001–2024)
Year-by-year capital reinvestment analysis for Yabao Pharmaceutical Group Co Ltd. For live market cap and broader valuation context, see how much is Yabao Pharmaceutical Group Co Ltd worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.07x | CN¥34.77 Million | CN¥471.69 Million | CN¥34.66 Million | ▼ -83.9% |
| 2023 | 0.46x | CN¥227.23 Million | CN¥497.55 Million | CN¥99.86 Million | ▲ +32.3% |
| 2022 | 0.35x | CN¥158.96 Million | CN¥460.46 Million | CN¥62.23 Million | ▲ +14.4% |
| 2021 | 0.30x | CN¥132.04 Million | CN¥437.50 Million | CN¥95.05 Million | ▼ -45.6% |
| 2020 | 0.55x | CN¥211.38 Million | CN¥380.96 Million | CN¥62.87 Million | ▲ +25.6% |
| 2019 | 0.44x | CN¥187.75 Million | CN¥425.17 Million | CN¥157.09 Million | ▲ +124.1% |
| 2018 | 0.20x | CN¥84.06 Million | CN¥426.60 Million | CN¥68.01 Million | ▼ -74.1% |
| 2017 | 0.76x | CN¥122.98 Million | CN¥161.73 Million | CN¥99.34 Million | ▲ +21.5% |
| 2016 | 0.63x | CN¥97.61 Million | CN¥155.95 Million | CN¥84.46 Million | ▼ -24.0% |
| 2015 | 0.82x | CN¥118.14 Million | CN¥143.47 Million | CN¥101.68 Million | ▼ -15.4% |
| 2014 | 0.97x | CN¥173.84 Million | CN¥178.63 Million | CN¥173.84 Million | ▼ -44.2% |
| 2013 | 1.74x | CN¥99.02 Million | CN¥56.80 Million | CN¥99.02 Million | ▼ -40.6% |
| 2011 | 2.94x | CN¥119.56 Million | CN¥40.73 Million | CN¥119.56 Million | ▼ -70.9% |
| 2010 | 10.09x | CN¥187.30 Million | CN¥18.57 Million | CN¥187.30 Million | ▲ +1278.1% |
| 2009 | 0.73x | CN¥269.82 Million | CN¥368.56 Million | CN¥269.82 Million | ▼ -48.9% |
| 2008 | 1.43x | CN¥147.56 Million | CN¥102.90 Million | CN¥147.56 Million | ▲ +384.1% |
| 2007 | 0.30x | CN¥31.31 Million | CN¥105.69 Million | CN¥31.31 Million | ▼ -92.1% |
| 2006 | 3.77x | CN¥43.70 Million | CN¥11.59 Million | CN¥43.70 Million | ▼ -8.7% |
| 2005 | 4.13x | CN¥108.95 Million | CN¥26.40 Million | CN¥108.95 Million | ▲ +62.3% |
| 2004 | 2.54x | CN¥202.81 Million | CN¥79.73 Million | CN¥202.81 Million | ▲ +125.7% |
| 2002 | 1.13x | CN¥27.38 Million | CN¥24.29 Million | CN¥27.38 Million | ▲ +15.4% |
| 2001 | 0.98x | CN¥23.04 Million | CN¥23.59 Million | CN¥23.04 Million | — |